Laboratory Biomarkers in the Clinical Management of COVID-19 and Post-COVID-19 Conditions

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Laboratory Medicine".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 223

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Laboratory Medicine, German Heart Centre Munich, TUM School of Medicine, Technical University of Munich, 80636 Munich, Germany
Interests: molecular diagnostics; cardiac biomarkers; cancer biomarkers; immunological diagnostics; molecular oncology; tumor markers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Sports Medicine, Rehabilitation and Disease Prevention, Institute of Sports Sciences, Johannes Gutenberg University of Mainz, Mainz, Germany
Interests: preventive medicine; sports medicine; exercise immunology; exercise science

Special Issue Information

Dear Colleagues,

During the COVID-19 pandemic, laboratory diagnostics created a considerable impact for i) the diagnosis of diseases, ii) the guidance of infected patients, and iii) the monitoring of the immune response after infection and vaccination. In everyday clinical diagnostics and in well-defined clinical trials, an enormous amount of data were collected that were helpful for the management of the pandemic and that still provide a lot of valuable insights for the preparation for new viral pandemics in the future. Thereby, the value of well-established laboratory parameters and the value of new molecular approaches for the characterization of the disease have been uncovered. However, a thoroughful evaluation of the abundant laboratory data is still ongoing in many places and deserves a platform for its focussed presentation. Therefore the aim of this Special Issue is to provide a comprehensive overview of studies on diagnostic markers that have shown great value for i) the early and accurate molecular diagnosis of the SARS CoV-2 virus via the use of diverse methods; ii) the diagnosis of COVID-19 disease and the estimation of the prognosis for the outcome of patients, particularly patients with diverse comorbidities; iii) the monitoring of disease courses and the early idenfitication of severe complications; iv) the time-related immune response to SARS CoV-2 infection; v) the humoral and cellular immune responses after the administration of diverse vaccinations in relation to predisposition, comorbidities, and side effects; vi) the identification of possible correlates of protection (COP) or predictions of risk (POR) for severe disease courses to define the period for timely booster vaccination; and finally, vii) the characterization of pathophysiological mechanisms that underly the development of long-COVID and biomarkers that support the prognosis and guidance of affected patients. Therefore, lab doctors, pathologists, researchers, and clinicians are encouraged to submit their findings as original articles or reviews to this Special Issue.

Prof. Dr. Stefan Holdenrieder
Prof. Dr. Perikles Simon
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19 pandemic
  • SARS CoV-2 detection
  • diagnostic and prognostic lab parameters
  • humoral and cellular immune response
  • therapy monitoring during infection
  • correlate of protection after vaccination
  • long-COVID

Published Papers

This special issue is now open for submission.
Back to TopTop